Home » Epilepsy Blog » News and Research » Give your feedback on a new epilepsy app

Give your feedback on a new epilepsy app

IMG_4177Your feedback will make this epilepsy app amazing

Living Well with Epilepsy is gearing up to provide an epilepsy digital application that will allow our readers to access a suite of health apps that can support self-care, and improve health outcomes. We are able to provide this thanks to a new partnership with Self Care Catalysts.
The epilepsy app is currently in development. At this stage Self Care Catalysts is looking to YOU for feedback to enhance the current suite of apps they have created. We want to be sure it can really meet the needs of a person living with epilepsy.

Join the discussion

We will be talking about the epilepsy app on January 19 or 20 between at 8 PM ET. Both dates are available depending on turnout. If you have time and are interested in providing feedback on what it means to live with epilepsy, let me know.
To participate, contact Living Well With Epilepsy via email by January 14. We will then have someone from the Self Care Catalysts team reach out to you to confirm details for the discussion.
I'm interested in giving feedback

 

author avatar
Jessica K. Smith Founder and CEO; Executive Director
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.